RXO heads into the week after its August earnings print with a sharp price rally sitting awkwardly against a wave of analyst target reductions — and options traders piling into puts at the highest rate in months.
The most striking tension is in options positioning. Downside protection demand has spiked to an unusual extreme: the put/call ratio jumped to 2.22 on August 7, more than four standard deviations above its 20-day average of 1.33. That is the highest reading in at least a year outside of a single outlier session, and it arrived on the same day the stock posted its best one-day gain in weeks — a 7.2% move to $21.70. That divergence is unusual. The stock bounced; options traders immediately bought more puts against it.
Short interest tells a quieter story, and that contrast matters. Bears hold just under 9% of the free float short — meaningful but not extreme — and that position has been slowly unwinding. SI fell roughly 1% across the week and is down from a recent peak near 9.4% in mid-July. Borrow conditions are genuinely comfortable: availability is running at around 407%, meaning roughly four shares are available to borrow for every one currently lent out. Cost to borrow is a near-trivial 0.43%, down 8% on the week. There is no squeeze pressure here, and no sign lenders are tightening supply. The short position looks like a residual drag, not an active bear thesis being pressed.
The Street's reaction to the earnings print has been swift but mixed in direction. Multiple firms cut targets on August 7 — UBS moved to $23 from $26, Citigroup cut to $23 from $30, and Truist trimmed to $28 from $30, all while maintaining their existing ratings. TD Cowen, which downgraded to Sell at the end of July, lowered again to $17.50. Against that cautious tide, Citizens upgraded to Market Outperform with a $30 target. The consensus remains a Hold, with 11 analysts parked there and two at outperform. The mean price target of $24.61 implies about 13% upside from current levels — enough to keep bulls interested, not enough to generate urgency. The EV/EBITDA multiple has compressed roughly 11% over the past 30 days to 20.5x, reflecting the re-rating after a weak revenue quarter. Factor scores add nuance: EPS momentum ranks in the 98th–100th percentile on both 30-day and 90-day windows, and the earnings surprise rank is at the 91st percentile. The short-score rank, by contrast, sits at just the 10th percentile — a sign that from a short-positioning perspective, the stock is relatively clean.
The bull and bear cases are well-defined. Bulls point to the Coyote integration lifting segment gross margins to 21%, up 40 basis points year-on-year, and Final Mile stop growth of 24% year-on-year as evidence that the franchise is expanding beyond brokerage. Bears focus on the revenue miss — $1.067 billion against expectations — driven by an 8% decline in truckload volumes, the automotive-sector softness that management flagged explicitly, and EPS estimates that have been revised down materially. The stock is down 19% over the past month even after this week's bounce, suggesting the market's re-rating of the near-term earnings path is not yet complete. Among correlated peers, LSTR gained 4.7% on the week and SAIA added 4.8%, while ARCB fell 4.6% — freight names moving in different directions, with RXO's 7.2% move outpacing most of the group on the day but still lagging the month-ago picture.
The key watch points from here are whether the unusual put/call spike on August 7 resolves as a one-session hedge or builds into sustained downside positioning, and whether the short position — which has been gradually reducing — continues to unwind as the post-earnings picture becomes clearer.
See the live data behind this article on ORTEX.
Open RXO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
